Sintilimab treatment for chronic active Epstein–Barr virus infection and Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis in children

BACKGROUND: Chronic active Epstein–Barr virus infection (CAEBV) and Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) are rare but life-threatening progressive diseases triggered by EBV infection. Glucocorticoid/immunosuppressants treatment is temporarily effective; however,...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ruyue, Lin, Qiang, Zhu, Yun, Shen, Yunyan, Xu, Qinying, Tang, Hanyun, Cui, Ningxun, Jiang, Lu, Dai, Xiaomei, Chen, Weiqing, Li, Xiaozhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514962/
https://www.ncbi.nlm.nih.gov/pubmed/37736751
http://dx.doi.org/10.1186/s13023-023-02861-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514962/
https://www.ncbi.nlm.nih.gov/pubmed/37736751
http://dx.doi.org/10.1186/s13023-023-02861-9

Ejemplares similares